Assessment of late urinary, bowel and sexual function after dose escalation from 70 to 76 Gy using image-guided radiotherapy in curative treatment of prostate cancer

References

• Larsen IK, Grimsrud TK, Haldorsen T, Johannesen TB, Johansen A, Langseth H, Cancer in Norway 2009. Cancer incidence, mortality, survival and prevalence in Norway. Oslo: Cancer Registry of Norway; 2011.
   Google Scholar
• Kvale R, Auvinen A, Adami HO, Klint A, Hernes E, Moller B, Interpreting trends in prostate cancer incidence and mortality in the five Nordic countries. J Natl Cancer Inst 2007;99:1881–7.
   PubMed Web of Science ®Google Scholar
• Bill-Axelson A, Holmberg L, Filen F, Ruutu M, Garmo H, Busch C, Radical prostatectomy versus watchful waiting in localized prostate cancer: the Scandinavian prostate cancer group-4 randomized trial. J Natl Cancer Inst 2008;100:1144–54.
   PubMed Web of Science ®Google Scholar
• Widmark A, Klepp Or, Solberg A, Damber JE, Angelsen A, Fransson P, Endocrine treatment, with or without radiotherapy, in locally advanced prostate cancer (SPCG-7/SFUO-3): an open randomised phase III trial. Lancet 2009;373:301–8.
   PubMed Web of Science ®Google Scholar
• Walsh PC, DeWeese TL, Eisenberger MA. Clinical practice. Localized prostate cancer. N Engl J Med 2007;357:2696–705.
   PubMed Web of Science ®Google Scholar
• Dearnaley DP, Sydes MR, Graham JD, Aird EG, Bottomley D, Cowan RA, Escalated-dose versus standard-dose conformal radiotherapy in prostate cancer: first results from the MRC RT01 randomised controlled trial. Lancet Oncol 2007;8:475–87.
   PubMed Web of Science ®Google Scholar
• Kuban DA, Tucker SL, Dong L, Starkschall G, Huang EH, Cheung MR, Long-term results of the M.D. Anderson randomized dose-escalation trial for prostate cancer. Int J Radiat Oncol Biol Phys 2008;70:67–74.
   PubMed Web of Science ®Google Scholar
• Al-Mamgani A, van Putten WL, Heemsbergen WD, van Leenders GJ, Slot A, Dielwart MF, Update of Dutch multicenter dose-escalation trial of radiotherapy for localized prostate cancer. Int J Radiat Oncol Biol Phys 2008;72:980–8.
   PubMed Web of Science ®Google Scholar
• Stephans KL, Xia P, Tendulkar RD, Ciezki JP. The current status of image-guided external beam radiotherapy for prostate cancer. Curr Opin Urol 2010;20:223–8.
   PubMed Web of Science ®Google Scholar
• Fransson P, Bergstrom P, Lofroth PO, Widmark A. Prospective evaluation of urinary and intestinal side effects after BeamCath stereotactic dose-escalated radiotherapy of prostate cancer. Radiother Oncol 2002;63:239–48.
   PubMed Web of Science ®Google Scholar
• Fransson P, Bergstrom P, Lofroth PO, Widmark A. Five-year prospective patient evaluation of bladder and bowel symptoms after dose-escalated radiotherapy for prostate cancer with the BeamCath(R) technique. Int J Radiat Oncol Biol Phys 2006;66:430–8.
   PubMed Web of Science ®Google Scholar
• Wei JT, Dunn RL, Litwin MS, Sandler HM, Sanda MG. Development and validation of the expanded prostate cancer index composite (EPIC) for comprehensive assessment of health-related quality of life in men with prostate cancer. Urology 2000;56:899–905.
   PubMed Web of Science ®Google Scholar
• Zelefsky MJ, Levin EJ, Hunt M, Yamada Y, Shippy AM, Jackson A, Incidence of late rectal and urinary toxicities after three-dimensional conformal radiotherapy and intensity-modulated radiotherapy for localized prostate cancer. Int J Radiat Oncol Biol Phys 2008;70:1124–9.
   PubMed Web of Science ®Google Scholar
• Siglin J, Kubicek GJ, Leiby B, Valicenti RK. Time of decline in sexual function after external beam radiotherapy for prostate cancer. Int J Radiat Oncol Biol Phys 2010;76:31–5.
   PubMed Web of Science ®Google Scholar
• Mykletun A, Dahl AA, O'Leary MP, Fossa SD. Assessment of male sexual function by the Brief Sexual Function Inventory. BJU Int 2006;97:316–23.
   PubMed Web of Science ®Google Scholar
• Hanssen S, Norum J. Bladder and rectal toxicity of BeamCath application in radiotherapy of prostate cancer. Anticancer Res 2008;28:2865–8.
   PubMed Web of Science ®Google Scholar
• Fonteyne V, Villeirs G, Lumen N, De Meerleer G. Urinary toxicity after high dose intensity modulated radiotherapy as primary therapy for prostate cancer. Radiother Oncol 2009;92:42–7.
   PubMed Web of Science ®Google Scholar
• Fransson P, Widmark A. Late side effects unchanged 4–8 years after radiotherapy for prostate carcinoma: a comparison with age-matched controls. Cancer 1999;85:678–88.
   PubMed Web of Science ®Google Scholar
• Bolla M, Collette L, Blank L, Warde P, Dubois JB, Mirimanoff RO, Long-term results with immediate androgen suppression and external irradiation in patients with locally advanced prostate cancer (an EORTC study): a phase III randomised trial. Lancet 2002;360:103–6.
   PubMed Web of Science ®Google Scholar
• Berg A, Dahl AA, Bruland OS, Bjoro T, Aanensen MS, Fossa SD. Definitive radiotherapy with adjuvant long-term antiandrogen treatment for locally advanced prostate cancer: health-related quality of life and hormonal changes. Prostate Cancer Prostatic Dis 2009;12:269–76.
   PubMed Web of Science ®Google Scholar
• Enzlin P, Mak R, Kittel F, Demyttenaere K. Sexual functioning in a population-based study of men aged 40–69 years: the good news. Int J Impot Res 2004;16:512–20.
   PubMed Web of Science ®Google Scholar
• van der Wielen GJ, Mulhall JP, Incrocci L. Erectile dysfunction after radiotherapy for prostate cancer and radiation dose to the penile structures: a critical review. Radiother Oncol 2007;84:107–13.
   PubMed Web of Science ®Google Scholar
• Teloken PE, Parker M, Mohideen N, Mulhall JP. Predictors of response to sildenafil citrate following radiation therapy for prostate cancer. J Sex Med 2009;6:1135–40.
   PubMed Web of Science ®Google Scholar
• McNair HA, Parker C, Hansen VN, Askew L, Mukherjee R, Nutting C, An evaluation of BeamCath in the verification process for prostate cancer radiotherapy. Clin Oncol (R Coll Radiol) 2004;16:138–47.
   PubMed Web of Science ®Google Scholar
• Poulsen PR, Fokdal L, Petersen J, Hoyer M. Accuracy of image-guided radiotherapy of prostate cancer based on the BeamCath urethral catheter technique. Radiother Oncol 2007;83:25–30.
   PubMed Web of Science ®Google Scholar